SciELO - Scientific Electronic Library Online

 
vol.31 número3Influência da COVID-19 nos doentes com varizes esofágicas submetidos a laqueação elástica profiláticaAtrofia vilositária do intestino delgado: um caso desafiante índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


GE-Portuguese Journal of Gastroenterology

versão impressa ISSN 2341-4545

GE Port J Gastroenterol vol.31 no.3 Lisboa jun. 2024  Epub 28-Jun-2024

https://doi.org/10.1159/000531380 

Clinical Case Study

Primary Gastric Tuberculosis in na Immunocompetent Patient: The Truth Lying beneath the Surface

Tuberculose gástrica primária num doente imunocompetente: A verdade escondida sob a superfície

Fábio Pereira Correia1 
http://orcid.org/0000-0001-6395-3405

Luísa Martins Figueiredo1 

Luís Carvalho Lourenço1  2 
http://orcid.org/0000-0002-2643-9359

Sofia Santos1 

Rita Theias Manso3 

David Horta1  2 

1Gastroenterology Department, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal;

2Gastroenterology Center, Cuf Tejo/ NOVA Medical School, Lisbon, Portugal;

3Pathological Anatomy Department, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal


Abstract

Gastrointestinal tuberculosis is an uncommon entity, in which clinical presentation can be widely variable, from mild and nonspecific symptoms to an acute abdomen and gastrointestinal bleeding. Gastric involvement by Mycobacterium tuberculosis is rare, especially when it occurs without other recognized infectious foci - primary gastric tuberculosis - with only a few reported cases. Endoscopic findings can be very heterogeneous, from areas of hyperemia to pseudotumor lesions. We present a case of primary gastric tuberculosis in an immuno-competent patient, in which the absence of an epidemiological context and nonspecificendoscopic findings led to a delay in the diagnosis. Bite-on-bite biopsies proved to be essential, allowing to obtain samples from deeper layers of the sub-mucosa where M. tuberculosis was identified. This case aimed to increase awareness for this entity, especially in endemic countries or regions with a high prevalence of tuberculosis since the diagnosis is based mainly on a high index of suspicion.

Keywords: Mycobacterium tuberculosis; Gastric tuberculosis; Bite-on-bite biopsies

Resumo

A tuberculose gastrointestinal é uma entidade pouco comum, com uma apresentação clínica amplamente variável, desde sintomas ligeiros e inespecíficos até quadros de abdómen agudo e hemorragia digestiva. O envolvimento gástrico pelo Mycobacterium tuberculosis é raro, especialmente quando ocorre sem outros focos infeciosos reconhecidos - tuberculose gástrica primária -, havendo apenas alguns casos descritos na literatura. Os achados endoscópicos podem ser muito heterogéneos, variando desde áreas de mucosa hiperemiada até lesões pseudo-tumorais. Apresentamos o caso de uma doente imunocompetente com diagnóstico de tuberculose gástrica primária, em que a ausência de um contexto epidemiológico e achados endoscópicos inespecíficos conduziram a um atraso no diagnóstico. As biópsias sobre biópsias mostraram ser essenciais para o diagnóstico, pois permitiram obter amostras de camadas mais profundas da submucosa do antro gástrico onde foi identificado o agente infecioso. Este caso pretende sensibilizar para existência desta entidade, especialmente em países endémicos ou regiões com alta prevalência de tuberculose, uma vez que o seu diagnóstico implica um elevado grau de suspeição.

Palavras Chave: Mycobacterium tuberculosis; Tuberculose gástrica; Biópsia em túnel

Introduction

Tuberculosis is an infectious disease caused by the bacillus Mycobacterium tuberculosis, and until the COVID-19 pandemic, it was the leading cause of death from a single infectious agent [1]. About 25% of the world’s population is infected with M. tuberculosis; however, only a small proportion will develop disease during their lifetime, with immunocompromised individuals being the most susceptible group. Although pulmonary tuberculosis is the most frequent manifestation, the involvement of other organs (extrapulmonary tuberculosis) is not negligible, and recent data show that, in some countries, extrapulmonary tuberculosis constitutes up to 30%of all active tuberculosis [2].

Gastrointestinal (GI) tuberculosis is an unusual form of extrapulmonary tuberculosis, although its prevalence may be underestimated due to its nonspecific clinical presentation. The ileocecal region is the most frequently affected site, followed by the colon and small intestine, while the stomach and esophagus are rarely involved [3]. We present a rare case of primary gastric tuberculosis with nonspecific clinical presentation and unsuspected endoscopic appearance, which made this diagnosis challenging.

Case Report

We present a case of a 46-year-old Portuguese woman, who was referred to the Gastroenterology Outpatient Clinic due to epigastric pain, early satiety at meals, and loss of >25% patient’s total weight for 3 months. Her past medical and family histories were irrelevant. The patient denied any other symptoms, and physical examination showed no changes. Laboratory tests (including blood count, coagulation, electrolytes, renal function, liver tests, and C-reactive protein) were normal. An upper GI endoscopy revealed diffusely hyperemic gastric mucosa, which was biopsied (antrum and gastric body). The patient was treated with pantoprazole 40 mg bid and domperidone 10 mg tid but without effect. Gastric biopsies revealed chronic gastritis with some atrophy and marked inflammatory activity with rare non-necrotizing epithelioid granulomas. No acid-fast bacilli (AFB) (Ziehl-Neelsen staining) were observed, and immunohistochemical for Helicobacter pylori was negative.

For investigation of granulomatous gastritis, a careful clinical history (without epidemiological context for tuberculosis) and additional laboratory tests were carried out: interferon gamma release assay negative; angiotensin-converting enzyme 45 U/L (reference range, 8-52 U/L); anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies negatives, fecal calprotectin 502 mg/kg (reference value: <50 mg/kg), and negative stool culture and ova and parasite analysis; HIV and VDRL negatives; erythrocyte sedimentation rate 10 mm/h (reference range: 0-20 mm/h); β2-microglobulin 1.3 mg/L (reference value: <2 mg/L); and normal peripheral blood smear. Chest and abdominopelvic CT scan did not reveal pulmonary nodules, lymph nodes, or digestive tract thickening. Colonoscopy with terminal ileoscopy and biopsies was performed - with no changes.

Six months later, after an extensive workup that was inconclusive, an upper GI endoscopy with biopsies was repeated. Once again, endoscopic findings were nonspecific, and the biopsies showed non-necrotizing epithelioid granulomas. Culture (Löwenstein-Jensen medium), immunohistochemistry (MPT64), and polymerase chain reaction (PCR) (GeneFinder TB) for M. tuberculosis were negatives. H. pylori was detected and treated with bismuth subcitrate potassium 140 mg qid, metronidazole 125 mg qid, and tetracycline 125 mg qid for 10 days.

The patient had worsening epigastric abdominal pain and persistent vomiting, unable to tolerate an adequate oral intake, so she was admitted to the Gastroenterology Department. At that time, an abdominopelvic CT was repeated revealing slight (13 mm) concentric parietal thickening of the gastric antrum (shown in Fig. 1). An upper GI endoscopy showed some gastric erosions (shown in Fig. 2), and biopsies were taken from body and antrum of the stomach. Bite-on-bite biopsies were performed in the antrum, and gastric juice was also collected for microbiological study.

Fig. 1. Abdominal CT scan. Concentric parietal thickening (13 mm) of the gastric antrum. 

Fig. 2 a, b  Upper GI endoscopy. Hyperemic mucosa and gastric erosions. 

Given the suspect of tuberculosis, a bronchoscopy was performed. Bronchial secretions and bronchoalveolar lavage were negative for M. tuberculosis in AFB staining (Ziehl-Neelsen), culture (Löwenstein-Jensen medium and BACTEC MGIT 960), and PCR (GeneXpert MTB/RIF). Capsule endoscopy excluded lesions in the small intestine.

Deep biopsies of the gastric antrum would reveal numerous epithelioid granulomas with central necrosis in the lamina propria (shown in Fig. 3, 4). AFB stain (Ziehl-Neelsen) and M. tuberculosis culture (Löwenstein-Jensen medium and BACTEC MGIT 960) were negative in both gastric juice and biopsies. PCR for M. tuberculosis in fresh samples of the antrum were negative, but positive in paraffin-embedded tissue (GeneFinder TB), thus making the diagnosis of gastric tuberculosis.

Fig. 3 a Hematoxylineosin stain (×4). Antrum-type gastric mucosa with moderate to severe chronic gastritis, with moderate activity, mild atrophy, and expansion of the lamina propria by inflammatory infiltrate, reactive lymphoid aggregates, and an epithelioid granuloma (arrow). b Hematoxylineosin stain (×20). Epithelioid granuloma with central necrosis, some neutrophils, and Langhans-type multinucleated giant cells. 

Fig. 4 Ziehl-Neelsen stain (×20). Granuloma. No acid-alcohol-resistant bacilli were identified. 

The patient was referred to Infectious Diseases and started treatment with isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, followed by 7 months of isoniazid and rifampin. There was a slow but complete clinical response at the end of treatment. Endoscopic reassessment with biopsies 3 months later was unremarkable, and fecal calprotectin was 95 mg/kg.

Discussion

Gastric tuberculosis is a rare entity, accounting for 0.5-3% of GI tuberculosis cases [4]. Several factors have been described that seem to be responsible for the rare gastric involvement, namely, (1) low pH in the gastric lumen, which has a bactericidal role; (2) the absence of lymphatic follicles; (3) the local immunity induced by the integrity of gastric mucosa; and (4) fast gastric emptying [3-5]. Most cases of gastric tuberculosis occur in patients with active pulmonary tuberculosis [6, 7], due to swallowing infected sputum, but it may also be secondary to hematogenous or lymphatic spread and contiguous spread from the adjacent organ. When no other tuberculosis foci are identified after an extensive workup, it is called primary gastric tuberculosis. The latest is a rare form of gastric tuberculosis, sometimes occurring in the context of ingestion of infected milk products and meat [3-5]. Interestingly, our patient did not have an epide-miological context nor a state of immunosuppression that would increase the risk of infection, which makes the case even more particular.

The few reported cases of gastric tuberculosis show that the clinical presentation is nonspecificand variable, from dyspeptic symptoms to acute GI bleeding and gastric perforation [4]. This characteristic along with the low index of suspicion for this entity, especially in non-endemic regions, is responsible for delayed diagnosis. Abdominal pain and vomiting were the main symptoms in this case, and according to a recent systematic review [8], they are present at diagnosis in 43.5%and 64.4% of cases, respectively. Constitutional symptoms associated with tuberculosis such as anorexia, weight loss, night sweats, fever, and fatigue may also be present. More rarely, presentation with an acute condition like upper GI bleeding or perforation has been described [4].

With regard to endoscopic findings, in our case, there were no specific lesions, only small erosions. However, ulcerated or hypertrophic gastric lesions, often causing strictures and mimicking gastric neoplasms, are consistently described in the literature [4, 5, 7, 8]. Lesions are more frequent in the lesser curvature of the gastric antrum, next to the pylorus, due to the presence of lymphoid follicles in this location and the high incidence of gastric ulcers in this topography, which break the integrity of the mucosa [8].

M. tuberculosis isolation proved to be the most challenging step in this case. Published data regarding the diagnostic sensitivity of the different methods in GI tuberculosis are mostly based on cases of intestinal tuberculosis. Interferon gamma release assay has a diagnostic sensitivity of 77-84%, failing to distinguish between latent and active infection. AFB staining, such as Ziehl-Neelsen, has a low diagnostic sensitivity (17-31%). M. tuberculosis culture has a high specificity, but a very variable sensitivity (usually less than 50%), being considered the gold standard for the diagnosis of intestinal tuberculosis. Disadvantages of the culture are the prolonged incubation time (6 weeks) and allowing only qualitative analysis [9, 10]. Histologically, the most typical findings are granulomas and caseous necrosis. Histopathological examination has a sensitivity of around 68%, and these findings are highly influenced by factors such as the number and quality of biopsies [9]. PCR examination has a very high specificity and a sensitivity ranging from 22 to 65%. Currently, there are fully automated real-time PCR methods (e.g., GeneXpert) that have a higher sensitivity (81-95.7%) and allow simultaneous detection of mutations related to the resistance of M. tuberculosis to rifampicin [9]. In summary, if diagnostic suspicion is high, several diagnostic methods should be explored. The PCR test is one of the most sensitive tests and should be used early.

The diagnostic yield of these methods may be com-promised in cases of gastric tuberculosis since the pathological findings may be present only in the sub-mucosa [8, 11]. Bite-on-bite biopsies (bites are taken sequentially at the same location to expose the sub-mucosa), as well as endoscopic ultrasound-guided biopsies, may be particularly useful in allowing the acquisition of histological material from deeper layers [12]. Although the bite-on-bite biopsy technique has a low diagnostic yield (23.3%) compared to endoscopic ultrasound-guided biopsy, it should be considered as an initial approach as it is cheaper, safer, and universally available [13, 14].

From the study carried out, it should be noted the elevation of fecal calprotectin around 10 times the upper limit of normality. Fecal calprotectin, a protein released by neutrophils, is a sensitive marker of in-flammation of the GI tract, being elevated not only in inflammatory bowel disease (IBD) but also in infectious diseases. The usefulness of this marker in the differential diagnosis of IBD and tuberculosis is limited since both entities show high values of the biomarker,

although very high values (>1,000 mg/kg) are sugges-tive of IBD. Studies have shown that a decrease in the fecal calprotectin level after antituberculosis therapy is an important indicator of therapeutic response in GI tuberculosis [15-18].

Antituberculosis drugs are the cornerstone of gastric tuberculosis treatment [7, 19]. Regarding the duration of treatment, although many physicians still consider a longer therapy (9-12 months) to be safer in terms of cure and risk of recurrence compared to the standard duration for pulmonary tuberculosis, there are several recent studies showing that 6-month regimens have been shown to have similar efficacy to 9-month regimens in recent studies [2, 3, 12]. Endoscopic and surgical approach should be reserved for more complex situations, such as cases of obstruction of the gastric tract outlet, GI bleeding, or perforation [4, 19].

In conclusion, primary gastric tuberculosis is a rare entity, whose clinical and endoscopic presentation can be very nonspecific. It is essential to have a high index of suspicion for this pathology, particularly in patients with an epidemiological context, to avoid delay in diagnosis and treatment. Bite-on-bite biopsies showed to be a cost-effective method in obtaining material for histological diagnosis.

References

1. Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. [ Links ]

2. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2022 - 2020. Copenhagen: WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control; 2022. Licence: CC BY 3.0 IGO. [ Links ]

3. Choi E, Coyle W. Gastrointestinal tuberculosis. Microbiol Spectr. 2016;4(6). [ Links ]

4. Chaudhary P, Khan A, Lal R, Bhadana U. Gastric tuberculosis. Indian J Tuberc. 2019; 66(3):411-7. [ Links ]

5. Debi U, Ravisankar V, Prasad K, Sinha S, Sharma A. Abdominal tuberculosis of the gastrointestinal tract: revisited. World J Gastroenterol. 2014;20(40):14831-40. [ Links ]

6. Seth A, Nijhawan V, Bhandari M, Dhaka RS, Kochar S. GastricTUBERCULOSIS: a case report. Med J Armed Forces India. 1998;54(3):278-9. [ Links ]

7. Shah J, Maity P, Kumar-M P, Jena A, Gupta P, Sharma V. Gastroduodenal tuberculosis: a case series and a management focused systematic review. Expert Rev Gastroenterol Hepatol. 2021;15(1):81-90. [ Links ]

8. Yan F, Yu X, Lei H, Chen Y, Wang J, Li J. A rare case of gastric fundus tuberculosis with nonspecific abdominal pain. J Int Med Res. 2021;49(7):03000605211033189. [ Links ]

9. Maulahela H, Simadibrata M, Nelwan E, RahadianiN, Renesteen E, Suwarti SWT, et al. Recent advances in the diagnosis of intestinal tuberculosis. BMC Gastroenterol. 2022;22(1):89. [ Links ]

10. Jha K, Pathiyil M, Sharma V. Evidence-based approach to diagnosis and management of abdominal tuberculosis. Indian J Gastroenterol. 2023;42(1):17-31. [ Links ]

11. Amarapurkar D, Patel N, Amarapurkar A. Primary gastric tuberculosis: report of 5 cases. BMC Gastroenterol. 2003;3:6. [ Links ]

12. Junare P, Rathi P. Gastroduodenal tuberculosis. Tuberculosis of the Gastrointestinal system. Springer; 2022. p. 59-72. [ Links ]

13. Zhu R, Zhou Y, Wang H, Di L, Zhao K, Tuo B, et al. Gastric tuberculosis mimicking submucosal tumor: a case series. BMC Gastroenterol. 2020;20(1):23. [ Links ]

14. Evans J, Halketson K, Ismail D, Leahy A, Fullard M, Richman P. Diagnostic yield and safety of 'bite on bite' tunneled biopsy for sampling of upper gastro-intestinal submucosal lesions. Gut. 2013;62:A144. [ Links ]

15. Jo H, Kim EY, Jung J, Kwon J, Kim ES, Lee H, et al. Value of fecal calprotectin measurement during the initial period of therapeutic antitubercular trial. Clin Endosc. 2022;55(2): 256-62. [ Links ]

16. Jung S, Kang S, Lee K. The usefulness of fecal calprotectin in diagnosis and follow-up of intestinal tuberculosis: prospective multicenter study: 192. Am J Gastroenterol. 2017; 112:S99. [ Links ]

17. Aguirre-Padilla L, Madrid-Villanueva B, Ugarte-Olvera M, Alonso-Soto J. Tuberculosis and crohn's disease: a challenging endoscopic diagnosis. A case report. Rev Gastroenterol Mex. 2022;87(1):113-6. [ Links ]

18. Larsson G, Shenoy K, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Bjune GA, et al. High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies. Infect Dis. 2015;47(3):137-43. [ Links ]

19. Arabi N, Musaad A, Ahmed E, Ibnouf M, Abdelaziz M. Primary gastric tuberculosis presenting as gastric outlet obstruction: a case report and review of the literature. J Med Case Rep. 2015;9:265. [ Links ]

1Statement of Ethics This study was reviewed and approved by Hospital Prof. Dr. Fernando Fonseca Ethics Committee. Written informed consent was obtained from the participant for publication of the details of their medical case and any accompanying images.

3Funding Sources The authors declare that no funds, grants, or other support was received during the preparation of this manuscript.

5Data Availability Statement All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

Received: February 12, 2023; Accepted: May 11, 2023

Correspondence to: Fábio Pereira Correia, fabioprcorreia@gmail.com

Conflict of Interest Statement The authors have no conflicts of interest to declare.

Author Contributions All the authors managed the patient; Fábio Pereira Correia and Luísa Martins Figueiredo drafted the paper; Sofia Santos, Rita Theias Manso, Luís Carvalho Lourenço, and David Horta critically revised the final version of the manuscript; all the authors approved the final version of the manuscript.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License